N124IN Spring 2013
Pathophysiology/Etiology Bacteria invades bone and soft tissues nearby Inflammation, ischemia occur Necrosis occurs in bone tissue Modes of entry by bacteria Direct inoculation Contiguous spread Hematogenous spread
Signs/symptoms Acute osteomyelitis Fever Local inflammation signs (tenderness, redness, heat, pain, swelling) Chronic osteomyelitis Ulceration Drainage Localized pain
Diagnostic Tests Increased WBC count Increased ESR Bone biopsy May have positive blood culture MRI, X-ray, CT scan
Therapeutic Measures Long-term antibiotic therapy Drainage Splinting Surgery to remove necrosis of bone tissue/place healthy bone tissue Amputations
Nursing Care Educate patient on IV antibiotic therapy Side effects, toxicity, interactions, precautions Home health care nurse may be necessary Use sterile technique when working with wound, if present Educate patient on wound care/dressing changes if applicable
Pathophysiology Imbalance in bone remodeling process years old: bone density peaks After this age, bone breakdown rate is greater than bone building rate Causes bones to be porous inside and weaker Can result in fractures
Types/Risk Factors Primary: not related to another disease or health condition Aging Female Caucasian/Asian/Hispanic/Latino Fracture history/family history Small bones/petite Postmenopausal Decreased testosterone/estrogen in males Decreased calcium/vitamin D intake Increased caffeine/protein/sodium intake Sedentary lifestyle Excessive alcohol intake Smoking
Types/Risk Factors, cont. Secondary: caused by medical condition/procedure Hyperparathyroidism Renal dialysis Steroids Antiseizure meds Sleeping meds Antacids with aluminum Hormones for endometriosis Cancer meds Extended immobility
Prevention Positive health habits and nutritional intake prior to age 30 Proper calcium and vitamin D intake Weight-bearing/muscle-strengthening exercises Decreased alcohol consumption Not smoking
Signs/symptoms Fracture Kyphosis Height decrease Back pain
Diagnostic Tests Computed Tomography Ultrasound Dual-energy x-ray absorptiometry (DEXA) Decreased serum calcium/vitamin D Increased serum phosphorus Alkaline phosphatase levels may be increased
Therapeutic Measures No cure Reduce Risk Factors Medications Calcium supplements Vitamin D
Therapeutic Measures, cont. Medications, cont. Antiresorptive drugs Bisphosphonates Prevent, slow osteoporosis progress Ex: alendronate (Fosamax), risedronate (Actonel), Synthetic thyroid hormone Decreases bone loss Ex: Calcitonin (Fortical, Miacalcin) Selective estrogen receptor modulator (SERM) Increases bone mass Ex: Raloxifene (Evista) Estrogen therapy Prevents bone loss related to menopause Bone-forming drugs Teriparatide (Forteo) Increases osteoblast action and number: increases bone mass
Therapeutic Measures, cont. Diet Increase calcium/vitamin D intake Calcium: years: 1000 mg/day >50 years: 1200 mg/day Vitamin D: years: 400 IU >70 years or with low sunlight: 600 IU
Therapeutic Measures, cont. Exercise Weight-bearing exercise Stimulates building of bones Resistance exercise
Fall prevention Assess home environment Educate patient family on creating environment that will help prevent falls No rugs No slippery floors No uneven areas Clutter free Proper shoes Provide walker or cane
Nursing Care Educate on prevention Pain relief Symptom care Education on medication
Pathophysiology 3 phases Active Osteoclasts increase and cause bone deformity and destruction Mixed Osteoblasts create new bone, but it is disorganized Inactive Occurs when osteoblast activity surpasses osteoclast activity Bone is sclerotic with high vascularity Common bones: spine, femur, skull, pelvis
Etiology Unknown cause Usually runs in families Could be related to latent viral infection from young adulthood
Signs/Symptoms Usually no symptoms, especially when only one bone is affected Pain Dependent on bone(s) Other medical conditions can occur Ex: heart failure
Diagnostic Tests X-rays Bone scans Increased serum alkaline phosphatase (ALP) Bone biopsy
Therapeutic Measures No cure Controlled by meds NSAIDs Bisphosphonates Synthetic thyroid hormone Exercise Surgery
Nursing Care Pain relief Symptom care Educate
Malignant tumors can be: Primary: originating in bone Metastatic: originating in other area of body and moving to bone Pathophysiology unique to bone cancer type Unknown cause
Primary Malignant Tumors Osteosarcoma/osteogenic sarcoma Most fatal tumor of bones Usually metastasizes to lungs in 2 years of diagnosis/treatment Typically involves people years old and boys more than girls Site of origin: typically long bones of arms, legs Signs: pain/swelling, lump, limp Diagnostic tests: X-ray, bone biopsy, CT scan, bone scan, MRI Treatments: chemotherapy, surgical removal with bone grafting or amputation
Primary Malignant Tumors, cont. Ewing’s sarcoma Bone tumor that is most malignant Signs/symptoms: local pain/swelling, low-grade fever, leukocytosis, anemia Often affects pelvis and legs in children and younger men
Primary Malignant Tumors, cont. Chondrosarcoma Cartilaginous cell cancer Better prognosis Typically occurs in middle-aged and elderly
Metastatic Bone Disease Bone-seeking cancers: primary malignant tumors in prostate, breast, lung, thyroid gland Once metastasized, numerous bone sites are usually found Important concerns: pathological fractures, severe pain
Signs/symptoms Primary tumors: Local swelling Pain Tender mass Metastatic disease Diffuse severe pain Can cause disability
Diagnostic Tests X-ray CT scan Bone scan Bone biopsy MRI Increased ALP Increased ESR
Therapeutic Measures Dependent on tumor type and extent Primary bone tumors Surgery Chemotherapy/radiation Metastatic bone disease No surgery External radiation Palliation
Nursing Care Assist patient with diagnosis Refer patient to appropriate resources Appropriate care with chemotherapy/radiation Postoperative care
5Cq_dPY 5Cq_dPY 5yQP4g4 5yQP4g4